FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 51 filers reported holding FORTRESS BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,000 | +40.0% | 2,533 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -28.6% | 2,533 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +75.0% | 2,533 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +100.0% | 2,533 | +53.7% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 1,648 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -88.0% | 1,648 | -94.2% | 0.00% | -100.0% |
| Q4 2018 | $25,000 | -28.6% | 28,540 | +28.4% | 0.00% | -33.3% |
| Q3 2018 | $35,000 | -98.3% | 22,221 | +3177.4% | 0.00% | – |
| Q2 2018 | $2,020,000 | +50400.0% | 678 | -30.0% | 0.00% | – |
| Q1 2018 | $4,000 | +300.0% | 969 | +182.5% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 343 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -50.0% | 343 | -61.2% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 885 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -40.0% | 885 | -50.8% | 0.00% | – |
| Q4 2016 | $5,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,887,500 | $12,323,000 | 1.61% |
| Nantahala Capital Management | 8,680,909 | $27,518,000 | 0.85% |
| SHIKIAR ASSET MANAGEMENT INC | 558,500 | $1,770,000 | 0.64% |
| CPWM, LLC | 506,267 | $1,605,000 | 0.15% |
| Sandbox Financial Partners, LLC | 14,650 | $46,000 | 0.04% |
| Sepio Capital, LP | 134,748 | $427,000 | 0.04% |
| 683 Capital Management, LLC | 200,000 | $635,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 22,928 | $73,000 | 0.01% |
| Virtu Financial LLC | 33,333 | $106,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 55,510 | $176,000 | 0.01% |